Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis-Reference-Cited by-同舟云学术

Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis

Published:2017-01-19 Issue:2 Volume:176 Page:395-402
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Matsushita T.¹,Mizumaki K.¹,Kano M.¹,Yagi N.¹,Tennichi M.¹,Takeuchi A.¹,Okamoto Y.¹,Hamaguchi Y.¹,Murakami A.²,Hasegawa M.³,Kuwana M.⁴,Fujimoto M.⁵,Takehara K.¹

Affiliation:

1. Department of Dermatology Faculty of Medicine Institute of Medical, Pharmaceutical and Health Sciences Kanazawa University Kanazawa 920‐8641 Japan

2. Medical and Biological Laboratories Co., Ltd Nagoya 460‐0008 Japan

3. Department of Dermatology University of Fukui Fukui 910‐1193 Japan

4. Department of Allergy and Rheumatology Nippon Medical School Graduate School of Medicine Tokyo 113‐8603 Japan

5. Department of Dermatology Faculty of Medicine University of Tsukuba Tennodai Tsukuba 305‐8575 Japan

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.14882

Reference32 articles.

1. Polymyositis and dermatomyositis

2. Dermatomyositis

3. Dermatomyositis

4. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

5. A novel autoantibody to a 155-kd protein is associated with dermatomyositis

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibody testing in myositis: an update;Current Opinion in Rheumatology;2024-08-20

2. Tacrolimus personalized therapy based on CYP3A5 genotype in Chinese patients with idiopathic inflammatory myopathies;Rheumatology;2024-06-18

3. The lung as a site for the generation of anti-MDA5 antibody in clinically amyopathic dermatomyositis;Rheumatology;2024-06-04

4. Serum interleukin-34 levels in dermatomyositis: a potential biomarker for anti-MDA5-antibody-associated interstitial lung disease;Rheumatology;2024-06-03

5. Unique characteristics of anti-MDA-5 associated dermatomyositis in Southern California with a large Hispanic population;Seminars in Arthritis and Rheumatism;2024-06